The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCIP.L Regulatory News (CIP)

  • There is currently no data for CIP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Correction : Form 8.3 - CIP Merchant Capital Ltd

22 Feb 2021 08:54

Lombard International Assurance S.A. - Correction : Form 8.3 - CIP Merchant Capital Ltd

Lombard International Assurance S.A. - Correction : Form 8.3 - CIP Merchant Capital Ltd

PR Newswire

London, February 22

AMENDMENT – CHANGE TO SECTION 2(A)

AMENDMENT – CHANGE TO SECTION 2(A)

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Lombard International Assurance S.A.
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. Lombard International Assurance S.A.
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeCIP Merchant Capital Limited
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure16/02/2021
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A”N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:Ordinary shares
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:1,350,000***2.4545--
(2) Cash-settled derivatives:----
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:----
TOTAL:1,350,0002.4545--

*** Lombard International Assurance S.A. does not have discretion regarding dealing and offer acceptance decisions in respect of 1,350,000 shares that are included in the total above.

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:-
Details, including nature of the rights concerned and relevant percentages:-

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/saleNumber of securitiesPrice per unit
----

(b) Cash-settled derivative transactions

Class of relevant securityProduct description e.g. CFDNature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
-----

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitType e.g. American, European etc.Expiry dateOption money paid/ received per unit
--------

(ii) Exercise

Class of relevant securityProduct description e.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
-----

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealing e.g. subscription, conversionDetailsPrice per unit (if applicable)
- ---

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer: Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to: (i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state “none”
None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:17 Feb. 21
Contact name:Thibaut Velghe Andreas Meier Head of Asset Oversight Chief Investment Officer
Telephone number*:+352 346191 285 +352 346191 220

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

Date   Source Headline
1st Dec 202112:16 pmRNSFurther Investment in Orthofix Medical Inc.
30th Nov 20217:00 amRNSNet Asset Value(s)
23rd Nov 20217:00 amRNSNet Asset Value(s)
16th Nov 20217:00 amRNSNet Asset Value(s)
9th Nov 20217:00 amRNSNet Asset Value(s)
5th Nov 20218:00 amEQSEdison Investment Research Limited: Channel Islands Property Fund (CIP): Initiation - Income is the name of the game
3rd Nov 20213:34 pmRNSInvestment in Medica SpA
2nd Nov 20217:00 amRNSNet Asset Value(s)
26th Oct 20217:00 amRNSNet Asset Value(s)
19th Oct 20217:00 amRNSNet Asset Value(s)
12th Oct 20217:00 amRNSNet Asset Value(s)
5th Oct 20217:00 amRNSNet Asset Value(s)
30th Sep 20217:00 amRNSInterim Results for the period ended 30 June 2021
28th Sep 20217:00 amRNSNet Asset Value(s)
21st Sep 20217:00 amRNSNet Asset Value(s)
14th Sep 20217:00 amRNSNet Asset Value(s)
10th Sep 20214:00 pmRNSResult of AGM
7th Sep 20217:00 amRNSNet Asset Value(s)
2nd Sep 20217:00 amRNSDirectorate Changes
1st Sep 20217:00 amRNSNet Asset Value(s)
24th Aug 20217:00 amRNSNet Asset Value(s)
18th Aug 20217:00 amRNSNotice of AGM
17th Aug 20217:00 amRNSNet Asset Value(s)
16th Aug 20217:00 amRNSProposed Further Investment in Brave Bison Group
10th Aug 20217:00 amRNSNet Asset Value(s)
3rd Aug 20217:00 amRNSNet Asset Value(s)
28th Jul 20218:51 amRNSDivestment of Proactis Holdings Plc
27th Jul 20217:00 amRNSNet Asset Value(s)
20th Jul 20217:00 amRNSNet Asset Value(s)
19th Jul 20219:09 amRNSHolding(s) in Company
15th Jul 202111:17 amRNSHolding(s) in Company
14th Jul 20213:42 pmRNSHolding(s) in Company
14th Jul 20213:40 pmRNSHolding(s) in Company
13th Jul 20217:00 amRNSNet Asset Value(s)
6th Jul 20214:46 pmRNSAvailability of Factsheet
6th Jul 20217:00 amRNSNet Asset Value(s)
5th Jul 20217:00 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSHolding(s) in Company
29th Jun 20217:00 amRNSNet Asset Value(s)
22nd Jun 20217:00 amRNSNet Asset Value(s)
21st Jun 20212:31 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSFurther investment in Ixico plc
15th Jun 20217:00 amRNSNet Asset Value(s)
8th Jun 20217:00 amRNSNet Asset Value(s)
2nd Jun 20217:00 amRNSNet Asset Value(s)
1st Jun 20217:00 amRNSFinal Results for the year ended 31 December 2020
25th May 20217:00 amRNSNet Asset Value(s)
18th May 20217:00 amRNSNet Asset Value(s)
11th May 20217:00 amRNSNet Asset Value(s)
5th May 20217:00 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.